< Back to search trials

A Phase II Open Label, Randomized Non-Comparative Trial of Nivolumab Alone or in Combination With Ipilimumab for the Treatment of Patients With Advanced Hypermutated Solid Tumors Detected by a Blood Based Assay

  • Clinicaltrials.gov #: NCT03461952
  • Acronym: NIMBLe
  • Tumor Type: Any histologically confirmed malignancy
  • Tumor Subtype: N/A
  • Tumor Stage: N/A
  • Type of Treatment: